Galmed Pharmaceuticals Ltd. Quarterly Common Stock, Value, Issued in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Galmed Pharmaceuticals Ltd. quarterly Common Stock, Value, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Galmed Pharmaceuticals Ltd. Common Stock, Value, Issued for the quarter ending June 30, 2024 was $263K, a 276% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $263K +$193K +276% Jun 30, 2024 6-K 2024-08-28
Q4 2023 $209K +$139K +199% Dec 31, 2023 6-K 2024-08-28
Q2 2023 $70K $0 0% Jun 30, 2023 6-K 2023-08-09
Q4 2022 $70K $0 0% Dec 31, 2022 20-F 2024-04-04
Q2 2022 $70K $0 0% Jun 30, 2022 6-K 2022-08-04
Q4 2021 $70K +$12K +20.7% Dec 31, 2021 20-F 2023-03-29
Q2 2021 $70K +$12K +20.7% Jun 30, 2021 6-K 2021-08-05
Q4 2020 $58K $0 0% Dec 31, 2020 20-F 2022-05-02
Q2 2020 $58K $0 0% Jun 30, 2020 6-K 2020-08-06
Q4 2019 $58K $0 0% Dec 31, 2019 20-F 2021-03-18
Q2 2019 $58K $0 0% Jun 30, 2019 6-K 2019-08-05
Q4 2018 $58K +$18K +45% Dec 31, 2018 20-F 2020-03-12
Q2 2018 $58K +$24K +70.6% Jun 30, 2018 6-K 2018-08-02
Q4 2017 $40K +$6K +17.6% Dec 31, 2017 20-F 2019-03-13
Q2 2017 $34K +$2K +6.25% Jun 30, 2017 6-K 2017-07-31
Q4 2016 $34K +$2K +6.25% Dec 31, 2016 20-F 2018-03-13
Q2 2016 $32K Jun 30, 2016 6-K/A 2017-06-23
Q4 2015 $32K $0 0% Dec 31, 2015 6-K/A 2017-06-23
Q4 2014 $32K +$22K +220% Dec 31, 2014 20-F 2016-03-22
Q4 2013 $10K Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.